MedPath
TGA Approval

VYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial (363250)

363250

VYXEOS daunorubicin (as hydrochloride) 44 mg and cytarabine 100 mg powder for injection vial

Jazz Pharmaceuticals ANZ Pty Ltd

June 3, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ee9599b0ef66559aaf91a7c011bc2e22.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/6cb756f08af0f7fda1eb85ed7bd7e6b6.pdf

Active Ingredients

cytarabine

daunorubicin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.